Cardiovascular Diseases Clinical Trial
Official title:
Effectiveness of the Aktivplan Digital Intervention for Supporting Regular Heart-healthy Levels of Physical Activity Following Completion of a Phase II Rehabilitation Programme: a Clinical Pilot Study
The goal of this clinical pilot / feasibility study is to determine the feasibility of conducting a large-scale clinical effectiveness trial of the aktivplan digital intervention in cardiac rehabilitation patients. The main questions this study aims to answer are: - Is it feasible to conduct a large-scale (fully powered) effectiveness trial of the aktivplan digital intervention? - What is the usability, user experience and user acceptance of the aktivplan digital intervention? Patients enrolled in a phase II cardiac rehabilitation programme will be randomly allocated to either the intervention group (aktivplan digital intervention) ot the usual care control group and followed-up for 10 weeks after discharge from cardiac rehabilitation. Patients in the intervention group will be given the aktivplan application (app) on their smartphone. A rehabilitation professional will plan a personalised heart-healthy physical activity plan together with the patient and enter it to the aktivplan app. The patient will be asked to follow their personal physical activity plan for 10 weeks, using the aktivplan app to document completed physical activity sessions. Patients in the control group will receive the usual standard of care without the aktivplan digital intervention. Researchers will analyse information such as the rate of recruitment, participant attrition, data completeness and technical stability of the app to determine the feasibility of conducting a large-scale clinical effectiveness trial.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | May 2024 |
Est. primary completion date | May 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Enrollment to a cardiac rehabilitation programme phase II, or a rehabilitation programme phase II due to non-cardiac indication but displaying cardiovascular risk factors - Ownership and use of a smartphone compatible with the aktivplan digital intervention and with internet connection - Agreement to attend the study follow-up visit - Written informed consent to take part in the study Exclusion Criteria: - Existing use of a digital intervention for regular heart-healthy physical activity - Medical contraindications for incremental cycle ergometry test - Medical contraindications for regular heart-healthy physical activity and sports - Medical contraindications for use of a smartphone - Inability to carry out cardiovascular training (e.g., due to significant musculoskeletal restrictions) - Participation in another clinical study within the past 6 months - Addiction or other medical conditions causing reduced decisional capacity - Pregnant women in the third trimester - Pregnant women in the first and second trimester with medical contraindication for physical activity and sports - Breastfeeding women with medical contraindication for physical activity and sports - Indication that patient is unlikely to follow study procedures (limited cooperation) |
Country | Name | City | State |
---|---|---|---|
Austria | REHA Zentrum Salzburg | Salzburg | |
Austria | Reha-Klinik Montafon | Schruns | Vorarlberg |
Lead Sponsor | Collaborator |
---|---|
Ludwig Boltzmann Institute for Digital Health and Prevention | REHA Zentrum Salzburg, Reha-Klinik Montafon |
Austria,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recruitment rate | Number of recruits per week | 10 weeks | |
Primary | Drop-out rate | Number of drop-outs in at the 10-week follow-up visit | 10 weeks | |
Primary | Data completeness | Percentage of missing data fields in the study database | 10 weeks | |
Primary | Adherence to the aktivplan digital intervention | Automated usage logging of the aktivplan mobile application (Matomo platform) | 10 weeks | |
Primary | Usability of the aktivplan digital intervention | mHealth App Usability Questionnaire (MAUQ) | 10 weeks | |
Primary | User experience of the aktivplan digital intervention | AttrakDiff Short Questionnaire | 10 weeks | |
Primary | User acceptance of the aktivplan digital intervention | Mobile Application Rating Scale (MARS) | 10 weeks | |
Primary | Technical stability of the aktivplan digital intervention | Number and types of technical problems (qualitative data) | 10 weeks | |
Primary | Use of alternative and additional strategies for supporting physical activity | Number and types of additional strategies (qualitative data) | 10 weeks | |
Primary | Experiences and perspectives of patients regarding their study participation | Qualitative data from semi-structured interviews | 10 weeks | |
Primary | Experiences and perspectives of rehabilitation professionals regarding the intervention and study procedures | Qualitative data from focus groups | 10 weeks | |
Secondary | Exercise capacity | Incremental cycle ergometry test | 10 weeks | |
Secondary | Physical activity behaviour | Moderate to vigorous physical activity (MVPA) | 10 weeks | |
Secondary | Weight | Weight in kg | 10 weeks | |
Secondary | Blood pressure | Blood pressure in mmHg | 10 weeks | |
Secondary | Blood cholesterol | Total cholesterol, HDL-cholesterol, non-HDL-cholesterol, total cholesterol / HDL-cholesterol ratio | 10 weeks | |
Secondary | HbA1c | HbA1c level | 10 weeks | |
Secondary | Smoking | Number and type of smoking products per week (qualitative data) | 10 weeks | |
Secondary | Health-related quality of life | EQ-5D-5L Questionnaire | 10 weeks | |
Secondary | Exercise self-efficacy | Exercise Self-Efficacy Scale (ESES) | 10 weeks | |
Secondary | Patient safety | Adverse events reporting (number and severity of adverse events) assessed by the Medical Device Coordination Group (MDCG) form | 10 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|